drugset

drugset / Trial / NCT00263055

MASCOT : Multicenter Asia Study in Adjuvant Treatment of Colon Cancer With OxaliplaTin/5FU-LV

NCT00263055 ↗

Phase 4 Completed Sanofi

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Safety \& tolerability of FOLFOX4 regimen in the adjuvant treatment of colon cancer in Asian patients

Timeline

Start: 2004-08
Primary completion: 2005-06
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Oxaliplatin	Small molecule	—	—

Indications